Please Note: This trial is no longer enrolling new participants
Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid?) Alone and in Combination with Epoetin Alfa (Procrit?) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia
| Protocol No. | E2905 | Scope | National |
|---|---|---|---|
| Principal Investigator | Kathy Miller | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
